SLDB logo

Solid Biosciences (SLDB) Depreciation And Amortization

Annual D&A

$2.58 M
+$173.00 K+7.18%

December 31, 2023

Summary

Performance

1-Year Change

+7.18%

3-Year Change

-34.19%

5-Year Change

+64.81%

15-Year Change

+476.12%

SLDB Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.76%
SLDB annual depreciation & amortization is higher than 54.76% of companies in Healthcare sector

High & Low

All-time High

$3.92 M
SLDB annual depreciation & amortization is currently -34.19% below its historical high of $3.92 million

3-Year Low

$2.41 M
SLDB annual depreciation & amortization is currently +7.18% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SLDB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
SLDB next annual earnings announcement is scheduled for Mar 13, 2025

Related metrics

Annual Total Expenses

$104.31 M
SLDB annual total expenses is $104.31 million

Annual Operating Expenses

$104.31 M
SLDB annual total operating expenses is $104.31 million

Annual Cost Of Goods Sold

-
SLDB annual cost of goods sold value is unknown

Annual Interest Expense

-
SLDB annual interest expense value is unknown

Quarterly D&A

$405.00 K
-$830.00 K-67.21%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SLDB Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.57%
SLDB quarterly depreciation & amortization is higher than 47.57% of companies in Healthcare sector

High & Low

All-time High

$1.33 M
SLDB quarterly depreciation & amortization is currently -69.64% below its historical high of $1.33 million

3-Year Low

$213.00 K
SLDB quarterly depreciation & amortization is currently +90.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLDB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLDB next earnings announcement is scheduled for Mar 13, 2025

Related metrics

Quarterly Total Expenses

$35.18 M
SLDB quarterly total expenses is $35.18 million

Quarterly Operating Expenses

$35.18 M
SLDB quarterly total operating expenses is $35.18 million

Quarterly Cost Of Goods Sold

-
SLDB quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$82.00 K
SLDB quarterly interest expense is $82.00 thousand

TTM D&A

$2.18 M
-$183.00 K-7.74%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SLDB TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.33%
SLDB TTM depreciation & amortization is higher than 52.33% of companies in Healthcare sector

High & Low

All-time High

$3.93 M
SLDB TTM depreciation & amortization is currently -44.56% below its historical high of $3.93 million

3-Year Low

$1.83 M
SLDB TTM depreciation & amortization is currently +19.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLDB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLDB next earnings announcement is scheduled for Mar 13, 2025

Related metrics

Annual Total Expenses

$104.31 M
SLDB annual total expenses is $104.31 million

Annual Operating Expenses

$104.31 M
SLDB annual total operating expenses is $104.31 million

TTM Cost Of Goods Sold

-
SLDB TTM cost of goods sold value is unknown

TTM Interest Expense

$265.00 K
SLDB TTM interest expense is $265.00 thousand

SLDB Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.2%0.0%0.0%
3 y3 years-34.2%0.0%0.0%
5 y5 years+64.8%0.0%0.0%

SLDB Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.9%+7.2%-67.2%+90.1%-26.4%+19.1%
5 y5-year-34.2%+7.2%-69.6%+90.1%-44.6%+19.1%
alltimeall time-34.2%-100.0%-69.6%+694.1%-44.6%+4174.5%

Solid Biosciences Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$405.00 K(-67.2%)
$2.18 M(-7.7%)
Jun 2024
-
$1.24 M(+277.7%)
$2.36 M(+29.1%)
Mar 2024
-
$327.00 K(+53.5%)
$1.83 M(-29.1%)
Dec 2023
$2.58 M(+7.2%)
$213.00 K(-63.8%)
$2.58 M(-11.2%)
Sep 2023
-
$588.00 K(-16.4%)
$2.91 M(+5.4%)
Jun 2023
-
$703.00 K(-34.7%)
$2.76 M(-0.7%)
Mar 2023
-
$1.08 M(+99.8%)
$2.78 M(+15.3%)
Dec 2022
$2.41 M(-18.8%)
$539.00 K(+23.1%)
$2.41 M(-8.4%)
Sep 2022
-
$438.00 K(-39.3%)
$2.63 M(-10.6%)
Jun 2022
-
$722.00 K(+1.8%)
$2.94 M(+0.1%)
Mar 2022
-
$709.00 K(-6.7%)
$2.94 M(-0.8%)
Dec 2021
$2.96 M(-24.4%)
$760.00 K(+1.2%)
$2.96 M(-1.2%)
Sep 2021
-
$751.00 K(+4.5%)
$3.00 M(-0.5%)
Jun 2021
-
$719.00 K(-2.0%)
$3.02 M(-16.9%)
Mar 2021
-
$734.00 K(-7.8%)
$3.63 M(-7.4%)
Dec 2020
$3.92 M
$796.00 K(+3.9%)
$3.92 M(-0.3%)
DateAnnualQuarterlyTTM
Sep 2020
-
$766.00 K(-42.6%)
$3.93 M(+0.1%)
Jun 2020
-
$1.33 M(+30.0%)
$3.93 M(+20.8%)
Mar 2020
-
$1.03 M(+27.3%)
$3.25 M(+15.2%)
Dec 2019
$2.82 M(+80.3%)
$806.00 K(+5.5%)
$2.82 M(+13.0%)
Sep 2019
-
$764.00 K(+16.1%)
$2.50 M(+9.6%)
Jun 2019
-
$658.00 K(+10.4%)
$2.28 M(+17.8%)
Mar 2019
-
$596.00 K(+23.9%)
$1.94 M(+23.6%)
Dec 2018
$1.57 M(+249.6%)
$481.00 K(-11.7%)
$1.57 M(+19.7%)
Sep 2018
-
$545.00 K(+74.1%)
$1.31 M(+49.8%)
Jun 2018
-
$313.00 K(+37.9%)
$873.00 K(+39.9%)
Mar 2018
-
$227.00 K(+1.8%)
$624.00 K(+39.3%)
Dec 2017
$448.00 K(+700.0%)
$223.00 K(+102.7%)
$448.00 K(+99.1%)
Sep 2017
-
$110.00 K(+71.9%)
$225.00 K(+95.7%)
Jun 2017
-
$64.00 K(+25.5%)
$115.00 K(+125.5%)
Mar 2017
-
$51.00 K
$51.00 K
Dec 2016
$56.00 K(>+9900.0%)
-
-
Dec 2015
$0.00
-
-

FAQ

  • What is Solid Biosciences annual depreciation & amortization?
  • What is the all time high annual D&A for Solid Biosciences?
  • What is Solid Biosciences annual D&A year-on-year change?
  • What is Solid Biosciences quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Solid Biosciences?
  • What is Solid Biosciences quarterly D&A year-on-year change?
  • What is Solid Biosciences TTM depreciation & amortization?
  • What is the all time high TTM D&A for Solid Biosciences?
  • What is Solid Biosciences TTM D&A year-on-year change?

What is Solid Biosciences annual depreciation & amortization?

The current annual D&A of SLDB is $2.58 M

What is the all time high annual D&A for Solid Biosciences?

Solid Biosciences all-time high annual depreciation & amortization is $3.92 M

What is Solid Biosciences annual D&A year-on-year change?

Over the past year, SLDB annual depreciation & amortization has changed by +$173.00 K (+7.18%)

What is Solid Biosciences quarterly depreciation & amortization?

The current quarterly D&A of SLDB is $405.00 K

What is the all time high quarterly D&A for Solid Biosciences?

Solid Biosciences all-time high quarterly depreciation & amortization is $1.33 M

What is Solid Biosciences quarterly D&A year-on-year change?

Over the past year, SLDB quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is Solid Biosciences TTM depreciation & amortization?

The current TTM D&A of SLDB is $2.18 M

What is the all time high TTM D&A for Solid Biosciences?

Solid Biosciences all-time high TTM depreciation & amortization is $3.93 M

What is Solid Biosciences TTM D&A year-on-year change?

Over the past year, SLDB TTM depreciation & amortization has changed by $0.00 (0.00%)